CORMEDIX INC. Debt Instrument, Face Amount
CORMEDIX INC. (CRMD) had Debt Instrument, Face Amount of $1.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2026-03-05
- 2025-12-31: Debt Instrument, Face Amount $1.00K.
- 2025-09-30: Debt Instrument, Face Amount $1.00K.
- 2025-08-12: Debt Instrument, Face Amount $150.00M.
- 2019-12-31: Debt Instrument, Face Amount $7.50M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2025-12-31 | $1.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-12 |
| 2025-08-12 | $150.00M 10-K · filed 2026-03-05 |
| 2019-12-31 | $7.50M 10-K · filed 2020-03-16 |
| 2019-09-30 | $7.50M 10-Q · filed 2019-11-14 |
| 2018-12-31 | $7.50M 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |